Search research articles
Contact Us
Filters
Showing results (21-30 of 363) with videos related to
Page
of 37
Sort By:
Discovery Medicine
|
November 16, 2013
Orphan drug development in muscular dystrophy: update on two large clinical trials of dystrophin rescue therapies
Eric P Hoffman, Edward M Connor
Journal of Neuromuscular Diseases
|
November 13, 2023
Reply to F. Muntoni et al.: "In response to P.R. Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy
Paula R Clemens, Eric P Hoffman
Annals of Neurology
|
May 5, 2021
Concerns Regarding Therapeutic Implications of Very Low-Level Dystrophin
Eric P Hoffman, Paula R Clemens
Current Neurology and Neuroscience Reports
|
May 15, 2010
Limb-girdle and congenital muscular dystrophies: current diagnostics, management, and emerging technologies
Carolina Tesi Rocha, Eric P Hoffman
Science Translational Medicine
|
April 4, 2014
Exon-skipping therapy: a roadblock, detour, or bump in the road?
Eric P Hoffman, Elizabeth M McNally
Nature Reviews. Neurology
|
September 19, 2012
Neuro-oncology: understanding the molecular complexity of medulloblastoma
Roger J Packer, Eric P Hoffman
Nature Medicine
|
June 1, 2004
Balancing muscle hypertrophy and atrophy
Eric P Hoffman, Gustavo A Nader
Nature Reviews. Neurology
|
June 12, 2023
Is it time for genetic modifiers to predict prognosis in Duchenne muscular dystrophy?
Luca Bello, Eric P Hoffman, Elena Pegoraro
Physiological Genomics
|
December 30, 2004
Intracellular expression profiling by laser capture microdissection: three novel components of the neuromuscular junction
Javad Nazarian, Khaled Bouri, Eric P Hoffman
Exercise and Sport Sciences Reviews
|
January 11, 2007
Proteomics and systems biology in exercise and sport sciences research
Dustin S Hittel, Yetrib Hathout, Eric P Hoffman
Page
of 37
Search research articles
Search
Showing results (21-30 of 363) with videos related to
Sort By:
Page
of 37
Discovery Medicine
|
November 16, 2013
Orphan drug development in muscular dystrophy: update on two large clinical trials of dystrophin rescue therapies
Eric P Hoffman, Edward M Connor
Journal of Neuromuscular Diseases
|
November 13, 2023
Reply to F. Muntoni et al.: "In response to P.R. Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy
Paula R Clemens, Eric P Hoffman
Annals of Neurology
|
May 5, 2021
Concerns Regarding Therapeutic Implications of Very Low-Level Dystrophin
Eric P Hoffman, Paula R Clemens
Current Neurology and Neuroscience Reports
|
May 15, 2010
Limb-girdle and congenital muscular dystrophies: current diagnostics, management, and emerging technologies
Carolina Tesi Rocha, Eric P Hoffman
Science Translational Medicine
|
April 4, 2014
Exon-skipping therapy: a roadblock, detour, or bump in the road?
Eric P Hoffman, Elizabeth M McNally
Nature Reviews. Neurology
|
September 19, 2012
Neuro-oncology: understanding the molecular complexity of medulloblastoma
Roger J Packer, Eric P Hoffman
Nature Medicine
|
June 1, 2004
Balancing muscle hypertrophy and atrophy
Eric P Hoffman, Gustavo A Nader
Nature Reviews. Neurology
|
June 12, 2023
Is it time for genetic modifiers to predict prognosis in Duchenne muscular dystrophy?
Luca Bello, Eric P Hoffman, Elena Pegoraro
Physiological Genomics
|
December 30, 2004
Intracellular expression profiling by laser capture microdissection: three novel components of the neuromuscular junction
Javad Nazarian, Khaled Bouri, Eric P Hoffman
Exercise and Sport Sciences Reviews
|
January 11, 2007
Proteomics and systems biology in exercise and sport sciences research
Dustin S Hittel, Yetrib Hathout, Eric P Hoffman
Page
of 37